FDA Recall Database: Class II Recall: Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75,… by Becton, Dickinson and Company

Key facts

What consumers should do

Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Specifically, check whether the product in your possession matches the description on file with FDA -- Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/096F6P, C144F7, 782F75M, 132F5, C146F7, 831F75/831F75P, TS105F5, 774F75, 777F8, AIQSGF8; -- and the recall number Z-2202-2026. If it matches, stop using or distributing it and contact Becton, Dickinson and Company or the point of purchase for return or replacement instructions. Retailers and distributors holding affected inventory should quarantine it and follow the firm's written recall notice. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do.

What this classification means

FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote. In this case, the recalling firm is Becton, Dickinson and Company and the affected product is described in FDA's record as: Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/096F6P, C144F7, 782F75M, 132F5, C146F7, 831F75/831F75P, TS105F5, 774F75, 777F8, AIQSGF8;. FDA's stated reason for the recall is: Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.. The recall is tracked under FDA recall number Z-2202-2026 and carries a status of Ongoing as of the most recent FDA enforcement report. This classification reflects FDA's assessment of the product defect described above, not a prediction about any specific patient outcome. FDA maintains a public enforcement report database so that consumers, physicians, and purchasers can look up the exact product identifiers involved before deciding what to do. Recall status can change while FDA and the recalling firm continue corrective actions, so checking the firm's own notice for the most current guidance is recommended.

Becton Dickinson & Company’s FDA history

Argus HQ has recorded 96 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 96 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

What was recalled and why?

Becton, Dickinson and Company recalled Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/096F6P, C144F7, 782F75M, 132F5, C146F7, 831F75/831F75P, TS105F5, 774F75, 777F8, AIQSGF8;. FDA's record states the reason for recall as: Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.. The recall is logged under FDA recall number Z-2202-2026 with a Class II classification.

How serious is this recall?

FDA classifies a recall as Class II when using the recalled product, or being exposed to it, may cause temporary or medically reversible adverse health consequences, or when the probability of serious adverse health consequences is remote.

What should someone who has this product do?

Because this recall carries FDA's middle severity classification, anyone who has this product should stop using it and follow the recalling firm's instructions, even though serious harm is considered unlikely for this classification. Check the product against FDA's description (Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/096F6P, C144F7, 782F75M, 132F5, C146F7, 831F75/831F75P, TS105F5, 774F75, 777F8, AIQSGF8;) and recall number Z-2202-2026, then follow Becton, Dickinson and Company's recall instructions.

Has Becton, Dickinson and Company had other FDA recalls or enforcement actions?

Yes. Argus HQ has recorded 96 total FDA actions tied to Becton, Dickinson and Company, including 96 recalls and 0 warning letters.

Related enforcement actions

• Recall: Becton Dickinson & Company — Class II recall: 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk… →
• Recall: Becton Dickinson & Company — Class II recall: BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341; →
• Recall: Becton Dickinson & Co. — Class II recall: BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100; →
• Recall: Becton Dickinson & Co. — Class II recall: BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 Syst… →
• Recall: Becton Dickinson & Co. — Class II recall: BD Phoenix M50 Instrument, labeled as the following: 1. BD Phoenix M50 Automa… →
• Recall: Becton Dickinson & Co. — Class II recall: BD MAX System, for in vitro diagnostic (IVD) use, labeled as the following: 1… →
• Recall: Becton Dickinson & Co. — Class II recall: BD BACTEC Blood Culture System, labeled as the following: 1. BD BACTEC FX, In… →
• Recall: Becton Dickinson & Co. — Class II recall: BD Veritor Connect Software, labeled as the following: 1. Veritor (NUC), Cata… →